ADAMTS13 gene mutations in children with hemolytic uremic syndrome

Hyoung Soo Choi1, Hae Il Cheong, Nam Keun Kim

  • 1Department of Pediatrics, Seoul National University Bundang Hospital, Seongnam, Korea.

Yonsei Medical Journal
|April 14, 2011
PubMed

Insights

Investigating ADAMTS13 activity and gene mutations in pediatric hemolytic uremic syndrome (HUS) revealed no significant differences from controls. Found mutations were not linked to reduced ADAMTS13 activity in these HUS patients.

Area of Science:

  • Pediatric Nephrology
  • Hematology
  • Human Genetics

Background:

  • Hemolytic uremic syndrome (HUS) is a severe condition often linked to ADAMTS13 dysfunction.
  • Investigating ADAMTS13 gene mutations and activity is crucial for understanding HUS pathogenesis in children.

Purpose of the Study:

  • To assess ADAMTS13 activity and identify ADAMTS13 gene mutations in pediatric patients with HUS.
  • To determine the correlation between ADAMTS13 activity, gene mutations, and HUS subtypes (D-HUS and D+HUS).

Main Methods:

  • Plasma ADAMTS13 activity was measured.
  • ADAMTS13 gene exons were analyzed using PCR amplification.
  • von Willebrand factor (VWF) degradation was assessed via multimer analysis.

Main Results:

  • ADAMTS13 activity levels in D-HUS and D+HUS patients were not statistically different from controls.
  • Five ADAMTS13 gene mutations (2 novel, 3 polymorphisms) were identified in a small subset of patients.
  • These identified mutations were not associated with decreased ADAMTS13 activity.

Conclusions:

  • ADAMTS13 activity is not significantly reduced in pediatric HUS patients studied.
  • The identified ADAMTS13 mutations in HUS patients did not correlate with reduced enzyme activity.
  • Further research is needed to clarify the role of these mutations in HUS development.

Related Concept Videos

Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Mutations01:39

Mutations

Overview
Mutations01:35

Mutations

Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...